No2(1) 2018
Back to the issue
|
DOI 10.37219/2528-8253-2018-2-39 |
Bereznyuk VV, Chornokur OA, Gospod OM
Application of Nasomer in surgical treatment of patients with polyposis
rhinosinusitis |
Bereznyuk Vladimir V.
Dnipropetrovsk Medical Academy, Head of the Department of Otolaryngology,
Doctor of Medical Sciences, Professor.
E-mail: otologg@gmail.com
Chernokur Alexander A.
Dnipropetrovsk Medical Academy, associate professor of the Department of
Otolaryngology, candidate of medical sciences.
E-mail: onkolog@rambler.ru
Orchid: https://orcid.org/0000-0003-1908-3929
Gospod Oleg N.
Dnipropetrovsk Medical Academy
Department of Otolaryngology
Assistant of the departmen |
|
Abstract
Relevance: Modern endonasal surgery allows to remove polyps from all
affected paranasal sinuses, following the principles of minimal
invasiveness. Minimal traumatic of surgical intervention gives the best
results, accompanied by less progression of the disease. Minimal
invasiveness of surgical intervention and its obligatory combination with
postoperative medical treatment are common practice in many countries. One
of the drugs that actively effect the restoration of the mucous membrane of
the nasal cavity and paranasal sinuses in the early postoperative period is
Nazomer, which includes sodium hyaluronate and dexpanthenol in saline
solution.
The purpose of the study is to investigate the effectiveness of the
drug Nazomer in patients with polyposis rhinosinusitis after endoscopic
polyposynosotomy.
Results and discussion: The main group consisted of 30 patients with
polyposis rhinosinusitis, who were prescribed Nasomer in addition to
standard treatment in the postoperative period. The control group included
30 patients who underwent standard treatment in the postoperative period.
As criteria for clinical efficacy, data from endoscopic examination of the
nasal cavity and indicators of anterior rhinomatometry, measured by the «Optimus»
device, were selected.
In the main group, the index of nasal breathing according to rhinomatometry
was better than the results of patients in the control group on the 3rd and
5th day of the postoperative period by 26% and 24%, respectively.
Conclusion: The use of the drug Nazomer in the postoperative period
in patients with polyposis rhinosinusitis contributes to more active
restoration of respiratory function of the nasal cavity compared with the
control group, according to rhinomatometry, up to 26%. Based on the results
obtained, the drug Nazomer is an effective anti-inflammatory and
regenerative agent in the postoperative period in patients with polyposis
rhinosinusitis. |
|
Keywords
poliposis rhinosinusitis, nasomer. |
|
Reference
- Bezshapochny WB, Podovzhny OG, Grishina IS. [Features of
postoperative treatment of patients after endonasal surgical
interventions]. Zhurnal vushnyh, nosovyh i gorlovyh hvorob.
2017;3-с:12-13. [Article in Ukrainian].
- Garyuk OG. [Rhinomanometry. Message 2: Current State and Prospects].
Rynologia. 2013;3:32-45. [Article in Ukrainian].
- Eroshin AL, Zaparov IP, Nechiporenko AS, Garyuk OG. [Objective
assessment of nasal breathing function according to rhinomanometry].
Vostochno-Evropeyskiy zhurnal peredovyih tehnologiy. 2014;4/9(70):48-50.
[Article in Russian].
- Demirbas D, Cingi Cl, Çakli H, Kaya E. Use of rhinomanometry in
common rhinologic disorders. Expert Rev. Med. Devices 2011;8(6),
769-777.
- Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et.
al. European position paper on rhinosinusitis and nasal polyps 2012.
Rhinol Suppl. 2012;50(23):1-298. doi: 10.2500/ajra.2013.27.3925.
- Ryan WR, Ramachandra T, Hwang PH. Correlations between symptoms,
nasal endoscopy, and inoffice computed tomography in post-surgical
chronic rhinosinusitis patients. Laryngoscope. 2011;121(3):674-678.
doi:
10.1002/lary.21394.
|
|
